# Randomized Comparison of Morning Versus Bedtime Administration of Aspirin: A Cardiovascular Circadian Chronotherapy (C3) Trial

Study · id `cardio:ct-nct05932472` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05932472](<https://clinicaltrials.gov/study/NCT05932472>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT05932472

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 32706 participants.

## Technical summary

Registry record NCT05932472. Randomized; no masking; primary purpose treatment. Start 2024-01-15 (actual); primary completion 2027-01-15 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 32706 participants (planned count; ClinicalTrials.gov record NCT05932472, source copy `cardio:ctgov-nct05932472-2024-02-06`, retrieved 2026-10-31)
- Started: 2024-01-15 (actual) (ClinicalTrials.gov record NCT05932472, source copy `cardio:ctgov-nct05932472-2024-02-06`, retrieved 2026-10-31)
- Primary completion: 2027-01-15 (anticipated) (ClinicalTrials.gov record NCT05932472, source copy `cardio:ctgov-nct05932472-2024-02-06`, retrieved 2026-10-31)
- Completion: 2027-02-15 (anticipated) (ClinicalTrials.gov record NCT05932472, source copy `cardio:ctgov-nct05932472-2024-02-06`, retrieved 2026-10-31)
- Countries: Denmark (ClinicalTrials.gov record NCT05932472, source copy `cardio:ctgov-nct05932472-2024-02-06`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05932472-2024-02-06`, retrieved 2026-10-31)

## The registry's words

- Brief title: Randomized Comparison of Morning Versus Bedtime Administration of Aspirin: A Cardiovascular Circadian Chronotherapy (C3) Trial
- Acronym: ASPIRIN-C3
- Condition: Atherosclerosis
- Condition: Cardiovascular Diseases
- Condition: Drug Effect
- Intervention (Drug): Aspirin
- Lead sponsor: Tor Biering-Sørensen
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Atherosclerosis (`cardio:atherosclerosis`)
- Registry intervention name matches this record: Aspirin (`core:aspirin`)
- Registry lists this organization as the lead sponsor: Tor Biering-Sørensen (`cardio:org-tor-biering-srensen-bf541f`)

## Provenance

Content hash: d87b70111127edc03b0900b6edcb5ee033feb2ddf15c637f2094654d66fc13c2
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
